Search
Now showing items 1-2 of 2
NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG
Wissenschaftlicher Artikel
(Universität Ulm, 2013)
Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia
Wissenschaftlicher Artikel
(Universität Ulm, 2013)